Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Jun 22;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. [Epub ahead of print]

PMID:
31301633
2.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-10. doi: 10.1080/21678421.2019.1632899. [Epub ahead of print]

PMID:
31284774
3.

Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.

Vucic S, Westeneng HJ, Al-Chalabi A, Van Den Berg LH, Talman P, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-6. doi: 10.1080/21678421.2018.1556697. [Epub ahead of print]

PMID:
31284763
4.

Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.

van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2818. doi: 10.3390/ijms20112818. Review.

5.

Immune checkpoint inhibitors and neuropathy: A new dawn.

Vucic S.

Clin Neurophysiol. 2019 Aug;130(8):1401-1402. doi: 10.1016/j.clinph.2019.05.004. Epub 2019 May 9. No abstract available.

PMID:
31101419
6.

Split elbow sign: more evidence for the importance of cortical dysfunction in ALS.

Vucic S.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):729. doi: 10.1136/jnnp-2019-320534. Epub 2019 Mar 25. No abstract available.

PMID:
30910859
7.

Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.

Garg N, Park SB, Howells J, Vucic S, Yiannikas C, Mathey EK, Nguyen T, Noto Y, Barnett MH, Krishnan AV, Spies J, Bostock H, Pollard JD, Kiernan MC.

Eur J Neurol. 2019 Aug;26(8):1121-1129. doi: 10.1111/ene.13953. Epub 2019 Apr 26.

PMID:
30882969
8.

The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS.

Dharmadasa T, Matamala JM, Howells J, Simon NG, Vucic S, Kiernan MC.

Neurosci Lett. 2019 Apr 23;699:84-90. doi: 10.1016/j.neulet.2019.01.050. Epub 2019 Jan 30.

PMID:
30710665
9.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
10.

Core temperature is not elevated at rest in people with relapsing-remitting multiple sclerosis.

Chaseling GK, Allen DR, Vucic S, Barnett M, Frohman E, Davis SL, Jay O.

Mult Scler Relat Disord. 2019 Apr;29:62-67. doi: 10.1016/j.msard.2019.01.013. Epub 2019 Jan 4.

PMID:
30684887
11.

Functional Biomarkers for Amyotrophic Lateral Sclerosis.

Huynh W, Dharmadasa T, Vucic S, Kiernan MC.

Front Neurol. 2019 Jan 4;9:1141. doi: 10.3389/fneur.2018.01141. eCollection 2018. Review.

12.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan 13.

PMID:
30636699
13.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.

Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, Lechner-Scott J, Barnett M, Grand'Maison F, Grammond P, Ramo-Tello C, Turkoglu R, McCombe P, Pucci E, Trojano M, Granella F, Spitaleri D, Van Pesch V, Soysal A, Oreja-Guevara C, Verheul F, Vucic S, Hodgkinson S, Slee M, Ampapa R, Prevost J, Menoyo JLS, Skibina O, Solaro C, Olascoaga J, Shaw C, Madsen KG, Naidoo K, Hyde R, Butzkueven H, Jokubaitis V; MSBase Study Group.

Mult Scler Relat Disord. 2019 Feb;28:235-243. doi: 10.1016/j.msard.2019.01.003. Epub 2019 Jan 3.

PMID:
30623864
14.

Utility of threshold tracking transcranial magnetic stimulation in ALS.

Vucic S, van den Bos M, Menon P, Howells J, Dharmadasa T, Kiernan MC.

Clin Neurophysiol Pract. 2018 Nov 17;3:164-172. doi: 10.1016/j.cnp.2018.10.002. eCollection 2018. Review.

15.

Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study.

Miller AE, Xu X, Macdonell R, Vucic S, Truffinet P, Benamor M, Thangavelu K, Freedman MS.

J Clin Neurosci. 2019 Jan;59:229-231. doi: 10.1016/j.jocn.2018.09.012. Epub 2018 Oct 20.

16.

Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS.

Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S.

Neurology. 2018 Oct 30;91(18):e1669-e1676. doi: 10.1212/WNL.0000000000006438. Epub 2018 Oct 3.

PMID:
30282772
17.

Miller Fisher Syndrome Associated With Immunotherapy for Metastatic Melanoma.

Baird-Gunning JJD, Weerasinghe D, Silsby M, Gawarikar Y, Carlino MS, Smith JL, Vucic S.

Neurohospitalist. 2018 Oct;8(4):191-193. doi: 10.1177/1941874418778957. Epub 2018 May 27.

PMID:
30245770
18.

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis.

Min M, Spelman T, Lugaresi A, Boz C, Spitaleri D, Pucci E, Grand'Maison F, Granella F, Izquierdo G, Butzkueven H, Sanchez-Menoyo JL, Barnett M, Girard M, Trojano M, Grammond P, Duquette P, Sola P, Alroughani R, Hupperts R, Vucic S, Kalincik T, Van Pesch V, Lechner-Scott J.

Mult Scler. 2018 Oct;24(12):1569-1577. doi: 10.1177/1352458518798147. Epub 2018 Sep 20.

PMID:
30234431
19.

Differences in inflammatory profiles between ALS and FTD.

Vucic S.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):1. doi: 10.1136/jnnp-2018-319377. Epub 2018 Sep 17. No abstract available.

PMID:
30224547
20.

Reproducibility of motor unit number index and multiple point stimulation motor unit number estimation in controls.

Higashihara M, Menon P, van den Bos M, Geevasinga N, Vucic S.

Muscle Nerve. 2018 Nov;58(5):660-664. doi: 10.1002/mus.26339. Epub 2018 Oct 15.

PMID:
30194855
21.

Patients' perspectives of multidisciplinary home-based e-Health service delivery for motor neurone disease.

James N, Power E, Hogden A, Vucic S.

Disabil Rehabil Assist Technol. 2018 Sep 5:1-7. doi: 10.1080/17483107.2018.1499139. [Epub ahead of print]

PMID:
30182780
22.

In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis.

Howells J, Matamala JM, Park SB, Garg N, Vucic S, Bostock H, Burke D, Kiernan MC.

J Physiol. 2018 Nov;596(22):5379-5396. doi: 10.1113/JP276624. Epub 2018 Oct 17.

PMID:
30175403
23.

Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels.

Garg N, Park SB, Howells J, Noto YI, Vucic S, Yiannikas C, Tomlinson SE, Huynh W, Simon NG, Mathey EK, Spies J, Pollard JD, Krishnan AV, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2162-2169. doi: 10.1016/j.clinph.2018.07.021. Epub 2018 Aug 10.

PMID:
30144659
24.

Fasciculation intensity and disease progression in amyotrophic lateral sclerosis.

Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2149-2154. doi: 10.1016/j.clinph.2018.07.015. Epub 2018 Aug 2.

PMID:
30114663
25.

Neurophysiological biomarkers in amyotrophic lateral sclerosis.

Vucic S, Rutkove SB.

Curr Opin Neurol. 2018 Oct;31(5):640-647. doi: 10.1097/WCO.0000000000000593. Review.

PMID:
30080715
26.

Comparison of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lateral sclerosis.

Noto YI, Garg N, Li T, Timmins HC, Park SB, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Yiannikas C, Vucic S, Kiernan MC.

Muscle Nerve. 2018 Dec;58(6):777-783. doi: 10.1002/mus.26301. Epub 2018 Oct 15.

PMID:
30019401
27.

Cortical excitability varies across different muscles.

Menon P, Kiernan MC, Vucic S.

J Neurophysiol. 2018 Sep 1;120(3):1397-1403. doi: 10.1152/jn.00148.2018. Epub 2018 Jul 5.

PMID:
29975162
28.

Consortium-based genome-wide meta-analysis for childhood dental caries traits.

Haworth S, Shungin D, van der Tas JT, Vucic S, Medina-Gomez C, Yakimov V, Feenstra B, Shaffer JR, Lee MK, Standl M, Thiering E, Wang C, Bønnelykke K, Waage J, Jessen LE, Nørrisgaard PE, Joro R, Seppälä I, Raitakari O, Dudding T, Grgic O, Ongkosuwito E, Vierola A, Eloranta AM, West NX, Thomas SJ, McNeil DW, Levy SM, Slayton R, Nohr EA, Lehtimäki T, Lakka T, Bisgaard H, Pennell C, Kühnisch J, Marazita ML, Melbye M, Geller F, Rivadeneira F, Wolvius EB, Franks PW, Johansson I, Timpson NJ.

Hum Mol Genet. 2018 Sep 1;27(17):3113-3127. doi: 10.1093/hmg/ddy237.

29.

Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, Zoing MC, Shibuya K, Geevasinga N, Vucic S, Hodges JR, Ahmed RM, Kiernan MC.

J Neurol. 2018 Aug;265(8):1819-1828. doi: 10.1007/s00415-018-8917-5. Epub 2018 Jun 4.

PMID:
29868980
30.

Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.

Agarwal S, Koch G, Hillis AE, Huynh W, Ward NS, Vucic S, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):47-57. doi: 10.1136/jnnp-2017-317371. Epub 2018 Jun 4. Review.

PMID:
29866706
31.

Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)].

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Menoyo JLS, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators.

Mult Scler Relat Disord. 2018 May;22:166. doi: 10.1016/j.msard.2018.02.025. Epub 2018 Feb 24. No abstract available.

PMID:
29807821
32.

Physiological Processes Underlying Short Interval Intracortical Facilitation in the Human Motor Cortex.

Van den Bos MAJ, Menon P, Howells J, Geevasinga N, Kiernan MC, Vucic S.

Front Neurosci. 2018 Apr 11;12:240. doi: 10.3389/fnins.2018.00240. eCollection 2018.

33.

Role Of spinal mechanisms in the pathophysiology of the split hand sign in amyotrophic lateral sclerosis.

Geevasinga N, Vucic S.

Muscle Nerve. 2018 Oct;58(4):470-471. doi: 10.1002/mus.26139. Epub 2018 May 17. No abstract available.

PMID:
29637578
34.

Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, Piguet O, Halliday G, Kiernan MC.

Nat Rev Neurol. 2018 May;14(5):259-271. doi: 10.1038/nrneurol.2018.23. Epub 2018 Mar 23. Review.

PMID:
29569624
35.

Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis.

Noto YI, Simon NG, Selby A, Garg N, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Park SB, Vucic S, Kiernan MC.

Clin Neurophysiol. 2018 May;129(5):974-980. doi: 10.1016/j.clinph.2018.01.061. Epub 2018 Feb 10.

PMID:
29554580
36.

Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.

Sheean RK, McKay FC, Cretney E, Bye CR, Perera ND, Tomas D, Weston RA, Scheller KJ, Djouma E, Menon P, Schibeci SD, Marmash N, Yerbury JJ, Nutt SL, Booth DR, Stewart GJ, Kiernan MC, Vucic S, Turner BJ.

JAMA Neurol. 2018 Jun 1;75(6):681-689. doi: 10.1001/jamaneurol.2018.0035.

37.

Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS.

Matamala JM, Howells J, Dharmadasa T, Trinh T, Ma Y, Lera L, Vucic S, Burke D, Kiernan MC.

Neurosci Lett. 2018 May 1;674:18-23. doi: 10.1016/j.neulet.2018.02.065. Epub 2018 Mar 1.

PMID:
29501687
38.

Rare and Common Variants Conferring Risk of Tooth Agenesis.

Jonsson L, Magnusson TE, Thordarson A, Jonsson T, Geller F, Feenstra B, Melbye M, Nohr EA, Vucic S, Dhamo B, Rivadeneira F, Ongkosuwito EM, Wolvius EB, Leslie EJ, Marazita ML, Howe BJ, Moreno Uribe LM, Alonso I, Santos M, Pinho T, Jonsson R, Audolfsson G, Gudmundsson L, Nawaz MS, Olafsson S, Gustafsson O, Ingason A, Unnsteinsdottir U, Bjornsdottir G, Walters GB, Zervas M, Oddsson A, Gudbjartsson DF, Steinberg S, Stefansson H, Stefansson K.

J Dent Res. 2018 May;97(5):515-522. doi: 10.1177/0022034517750109. Epub 2018 Jan 24.

39.

Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod.

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Sánchez-Menoyo JL, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators.

Mult Scler Relat Disord. 2018 Jan;19:105-108. doi: 10.1016/j.msard.2017.11.018. Epub 2017 Nov 22.

PMID:
29182993
40.

Dysphagia in Multiple Sclerosis: Evaluation and Validation of the DYMUS Questionnaire.

Alali D, Ballard K, Vucic S, Bogaardt H.

Dysphagia. 2018 Jun;33(3):273-281. doi: 10.1007/s00455-017-9864-5. Epub 2017 Nov 17. Review.

PMID:
29147920
41.

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.

Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, White OB, Broadley S, Lechner-Scott J, Vucic S, Henderson APD, Barnett MH, Reddel SW, Brilot F, Dale RC; Australasian and New Zealand MOG Study Group.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15.

42.

Plasma creatinine: a potential prognostic biomarker in amyotrophic lateral sclerosis?

Vucic S.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):119. doi: 10.1136/jnnp-2017-317413. Epub 2017 Nov 15. No abstract available.

PMID:
29142144
43.

Ancestry and dental development: A geographic and genetic perspective.

Dhamo B, Kragt L, Grgic O, Vucic S, Medina-Gomez C, Rivadeneira F, Jaddoe VWV, Wolvius EB, Ongkosuwito EM.

Am J Phys Anthropol. 2018 Feb;165(2):299-308. doi: 10.1002/ajpa.23351. Epub 2017 Nov 15.

44.

Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.

Garg N, Park SB, Yiannikas C, Vucic S, Howells J, Noto YI, Mathey EK, Pollard JD, Kiernan MC.

Muscle Nerve. 2018 May;57(5):848-851. doi: 10.1002/mus.26010. Epub 2017 Nov 29.

PMID:
29130507
45.

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

Kalincik T, Manouchehrinia A, Sobisek L, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Girard M, Prat A, Duquette P, Grammond P, Sola P, Hupperts R, Grand'Maison F, Pucci E, Boz C, Alroughani R, Van Pesch V, Lechner-Scott J, Terzi M, Bergamaschi R, Iuliano G, Granella F, Spitaleri D, Shaygannejad V, Oreja-Guevara C, Slee M, Ampapa R, Verheul F, McCombe P, Olascoaga J, Amato MP, Vucic S, Hodgkinson S, Ramo-Tello C, Flechter S, Cristiano E, Rozsa C, Moore F, Luis Sanchez-Menoyo J, Laura Saladino M, Barnett M, Hillert J, Butzkueven H; MSBase Study Group.

Brain. 2017 Sep 1;140(9):2426-2443. doi: 10.1093/brain/awx185.

PMID:
29050389
46.

Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?

Vucic S.

Eur J Neurol. 2018 Jan;25(1):1-2. doi: 10.1111/ene.13470. Epub 2017 Nov 6. No abstract available.

PMID:
28940741
47.

Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability.

Geevasinga N, Korgaonkar MS, Menon P, Van den Bos M, Gomes L, Foster S, Kiernan MC, Vucic S.

Eur J Neurol. 2017 Dec;24(12):1507-1517. doi: 10.1111/ene.13461. Epub 2017 Oct 7.

PMID:
28926154
48.

Hyperpolarization-activated cyclic-nucleotide-gated channels potentially modulate axonal excitability at different thresholds.

Weerasinghe D, Menon P, Vucic S.

J Neurophysiol. 2017 Dec 1;118(6):3044-3050. doi: 10.1152/jn.00576.2017. Epub 2017 Sep 13.

49.

Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss.

Garg N, Howells J, Yiannikas C, Vucic S, Krishnan AV, Spies J, Bostock H, Mathey EK, Pollard JD, Park SB, Kiernan MC.

Clin Neurophysiol. 2017 Oct;128(10):2022-2028. doi: 10.1016/j.clinph.2017.07.414. Epub 2017 Aug 7.

PMID:
28837908
50.

Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy.

Matamala JM, Geevasinga N, Huynh W, Dharmadasa T, Howells J, Simon NG, Menon P, Vucic S, Kiernan MC.

Clin Neurophysiol. 2017 Aug;128(8):1488-1495. doi: 10.1016/j.clinph.2017.05.005. Epub 2017 May 17.

PMID:
28624492

Supplemental Content

Support Center